PERSPECTA

News from every angle

← Back to headlines

Merck's Keytruda and Padcev Combination Approved in EU for Bladder Cancer

Merck has received European Union approval for its Keytruda and Padcev combination therapy for the treatment of bladder cancer.

24 Jun, 11:49 — 24 Jun, 11:49
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed54d ago

Merck gains EU approval of Keyruda, Padcev combo for bladder cancer

Read full article →

Related Stories

Gold Prices Rise as Dollar Weakens on Reduced Fed Rate Hike Bets

15m ago

Duna Aszfalt Returns €150 Million Advance for Mohács Danube Bridge Project

40m ago

Gold Prices Rise on Easing Rate-Hike Concerns

49m ago

Nvidia Backs OpenAI's New Ohio Data Center with $105 Billion Guarantee

58m ago